1198154-03-8

Basic information

• Product Name: 7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
• Synonyms: 7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
• CAS NO: 1198154-03-8
• Molecular Weight: 226.235
• Mol File: 1198154-03-8.mol

Chemical Properties

• CAS DataBase Reference: 7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one(1198154-03-8)
• EPA Substance Registry System: 7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one(1198154-03-8)

Safety Data

• Hazardous Substances Data: 1198154-03-8(Hazardous Substances Data)

Upstream product

• 1313441-32-5 ethyl 2-((3-nitro-5-phenylpyridin-2-yl)oxy)acetate 
• 67443-38-3 5-bromo-2-chloro-3-nitropyridine 
• 105544-30-7 ethyl-2-((5-bromo-3-nitropyridin-2-yl)oxy)acetate 
• 105544-36-3 7-bromo-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 
• 98-80-6 phenylboronic acid 

Downstream Products

• 1313441-33-6 6-bromo-7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one 
• 1313441-54-1 6-bromo-7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-thione 
• 1313441-55-2 7-bromo-1-(difluoromethyl)-8-phenyl-4H-pyrido[2,3-b][1,2,4]triazolo[4,3-d][1,4]oxazine 
• 1313441-64-3 tert-butyl 4-(2-oxo-7-phenyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)benzylcarbamate 
• 1313441-65-4 tert-butyl 4-(1-(cyanomethyl)-2-oxo-7-phenyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)benzylcarbamate 
• 1313485-80-1 (E)-6-bromo-2-hydrazono-7-phenyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine 
• 1313441-66-5 7-bromo-1-ethyl-8-phenyl-4H-pyrido[2,3-b][1,2,4]triazolo[4,3-d][1,4]oxazine 
• 1198154-04-9 7-phenyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine 

Relevant articles and documents

HETEROCYCLIC DERIVATIVES

The present invention relates to heterocyclic derivatives, and more particularly, to novel heterocyclic derivatives useful for the preparation of medicaments for treating diseases related to uric acid.

INHIBITORS OF AKT ACTIVITY

The invention relates to a series of compounds with particular activity as inhibitors of the serine-threonine kinase AKT. Also provided are pharmaceutical compositions comprising same as well as methods for treating cancer.